Targeting multiplicity: the key factor for anti-cancer nanoparticles

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Effective cancer treatment requires precise delivery of therapeutic agents to tumor sites.
• Nanoparticles offer potential for targeted drug delivery but face challenges in reaching cancer cells specifically.
• Current strategies often lack the necessary specificity, leading to off-target effects.

Purpose of the Study:

• To review and analyze diverse strategies for enhancing the targeting of nanomedicines to cancer cells.
• To discuss the integration of tumor microenvironment features, nanoparticle properties, and external stimuli for improved cancer cell specificity.
• To emphasize the synergistic potential of passive and active targeting approaches in nanomedicine for cancer therapy.

Main Methods:

• Literature review of current nanomedicine targeting strategies.
• Analysis of passive targeting mechanisms (e.g., enhanced permeability and retention effect).
• Evaluation of active targeting approaches utilizing biomarkers and physical methods for non-invasive therapies.

Main Results:

• Combining passive and active targeting strategies significantly enhances nanomedicine specificity for cancer cells.
• Leveraging tumor microenvironment characteristics and overexpressed biomarkers improves nanoparticle accumulation and retention.
• Physical methods offer non-invasive means to guide and activate nanomedicines at the tumor site.

Conclusions:

• A multifaceted approach integrating passive and active targeting is crucial for achieving high specificity in cancer nanomedicine.
• Optimizing nanoparticle design and understanding tumor biology are key to successful cancer cell targeting.
• Synergistic strategies promise to improve the efficacy and safety of nanotherapeutics in oncology.